Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MPS VI Clinical Surveillance Program (CSP)

NCT00214773 is registered in ClinicalTrials.gov with BioMarin Pharmaceutical as lead sponsor.

NCT NCT00214773
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00214773 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MPS VI Clinical Surveillance Program (CSP)
Lead sponsor
BioMarin Pharmaceutical
Phase
Observational
Overall status
Completed
Start date
July 31, 2005
Completion date
May 1, 2020
Enrollment
237 (actual)
Sites
50

Conditions

As the registry lists them; a condition with its own page is linked.

mucopolysaccharidosis vi (mps vi, maroteaux-lamy syndrome)